Neurocognitive & Delirium
Medication-Induced Movement
≥3 of 12 catatonia symptoms: stupor; catalepsy; waxy flexibility; mutism; negativism; posturing; mannerism; stereotypy; agitation; grimacing; echolalia; echopraxia
Dopamine antagonist exposure (antipsychotic or antiemetic) and development of severe muscle rigidity and elevated temperature
B. Associated with another mental disorder / due to another medical condition / unspecified (determines specifier applied)
B. ≥2 of: diaphoresis; dysphagia; tremor; incontinence; change in level of consciousness (confusion to coma); mutism; tachycardia; elevated/labile BP; leukocytosis; elevated CK C. Not attributable to another substance or medical/neurological condition
A. ≥3 of 12 catatonia symptoms: stupor; catalepsy; waxy flexibility; mutism; negativism; posturing; mannerism; stereotypy; agitation; grimacing; echolalia; echopraxia B. Associated with another mental disorder / due to another medical condition / unspecified (determines specifier applied)
A. Dopamine antagonist exposure (antipsychotic or antiemetic) and development of severe muscle rigidity and elevated temperature B. ≥2 of: diaphoresis; dysphagia; tremor; incontinence; change in level of consciousness (confusion to coma); mutism; tachycardia; elevated/labile BP; leukocytosis; elevated CK C. Not attributable to another substance or medical/neurological condition
Catatonia associated with another mental disorder; Catatonic disorder due to another medical condition; Unspecified catatonia; With stupor
Associated with antipsychotic exposure; Associated with dopaminergic withdrawal; With severe rhabdomyolysis; Severity (Mild / Moderate / Severe)
NMS (fever, rigidity, markedly elevated CK - urgent); Serotonin syndrome (hyperthermia, clonus, diaphoresis); Non-convulsive status epilepticus (EEG essential)
Serotonin syndrome (hyperthermia + clonus + diaphoresis + hyperreflexia - starts within 24 hrs; clonus distinguishes from NMS rigidity); Malignant hyperthermia (anaesthetic trigger; volatile agents/suxamethonium; ryanodine receptor mutation); Lethal catatonia (treatment with ECT; NMS and lethal catatonia may overlap)